Join today and have your say! It’s FREE!

We will not release or resell your information to third parties without your permission.

Please Try Again

{{ error }}

By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Please Try Again

{{ error }}

Password Hint : {{passwordHint}}

Remember me

Forgot Password?

or

Privacy Policy | Disclaimer

Quote | Bullboard | News | Opinion | Profile | Peers | Filings | Financials | Options | Price History | Ratios | Ownership | Insiders | Valuation

Breaking & Recent News GSK American Depositary Shares Representing 2 Ordinary Shares GSK

Consumer Cyclical

GSK plc is a global biopharma company. The Company’s segments include Commercial Operations and Research and Development. It develops cancer medicines for patients, including ovarian cancer, endometrial cancer, and multiple myeloma. Its product areas include vaccines, specialty medicines, and general medicine. It is also focused on addressing the unmet treatment needs of patients with... see more

Add To Watchlist

Recent & Breaking News (NYSE:GSK)

GSK, United Way of Greater Philadelphia and Southern New Jersey Issue Call for Applications Totaling $400,000 in GSK IMPACT Awards

PR Newswire May 6, 2014

GSK receives approval for Incruse(TM) Ellipta® (umeclidinium) in the US for the treatment of COPD

PR Newswire April 30, 2014

GSK CFO Interviewed on Q1 Results 2014

PR Newswire April 30, 2014

Anoro(TM) Ellipta® now available in the US for treatment of COPD

PR Newswire April 28, 2014

Anoro(TM) Ellipta(R) Now Available in the US for Treatment of COPD

Marketwired April 28, 2014

Anoro(TM) Ellipta(R) Now Available in the US for Treatment of COPD

Marketwired April 28, 2014

Theralase Could Light Up Cancer Therapeutics

Accesswire April 24, 2014

GSK and Theravance Announce Phase III Study of Fluticasone Furoate/Vilanterol in COPD Commenced to Support Potential Future Filing in Japan

Marketwired April 22, 2014

GSK and Theravance Announce Phase III Study of Fluticasone Furoate/Vilanterol in COPD Commenced to Support Potential Future Filing in Japan

Marketwired April 22, 2014

GSK and Genmab receive FDA approval for Arzerra® (ofatumumab) as first-line treatment in combination with chlorambucil for patients with Chronic Lymphocytic Leukaemia (CLL) for whom fludarabine-based therapy is considered inappropriate

PR Newswire April 17, 2014

GSK announces approval in Canada for Incruse(TM) Ellipta(TM) (umeclidinium) as a treatment for COPD

Canada NewsWire April 17, 2014

GSK receives US approval for once-weekly type 2 diabetes treatment, Tanzeum(TM) (albiglutide)

PR Newswire April 15, 2014

GlaxoSmithKline (GSK) embroiled in Iraq bribery allegations

Canadian Press April 7, 2014

Gilead's (GILD) Blockbuster Hepatitis-C Drug Sovaldi Steps Up Race

Equities.com April 7, 2014

ViiV Healthcare announces new initiatives to improve access to dolutegravir: licence to the Medicines Patent Pool

PR Newswire April 1, 2014

Apply Market Savvy to Bear Market Debris; Uncover Biotech Treasures: Cleland and Ireland

Equities.com March 24, 2014

GSK's MAGE-A3 Cancer Immunotherapeutic Phase 3 Study in Non-Small Cell Lung Cancer Misses First Co-Primary Endpoints

Business Wire March 20, 2014

ViiV Healthcare Announces Next Round of the Positive Action Southern Initiative to Support Linkages to HIV/AIDS Care and Treatment Adherence

PR Newswire March 19, 2014

GSK and Theravance Announce Positive Results From Studies Comparing ANORO(TM) ELLIPTA(TM) With SERETIDE(R) DISKUS(R) and ADVAIR(R) DISKUS(R) in Patients With COPD

Marketwired March 14, 2014

Patient Recruitment Completes in Landmark RELVAR(R)/BREO(R) ELLIPTA(R) Study to Understand Mortality and MorbidITy (SUMMIT) in COPD

Marketwired March 13, 2014